Related references
Note: Only part of the references are listed.Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin
Nicholas F. Dybdal-Hargreaves et al.
Oncotarget (2018)
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases
Takashi Mizuno et al.
EJSO (2018)
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
Yoshiya Horimoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures
Elizabeth H. Kellogg et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
Hiroyuki Ozawa et al.
CLINICAL CANCER RESEARCH (2017)
Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis
Xing Shugang et al.
TRANSLATIONAL ONCOLOGY (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Saber Imani et al.
SCIENTIFIC REPORTS (2016)
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
Margaret M. Kozak et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury
Vera Valakh et al.
NEUROBIOLOGY OF DISEASE (2015)
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
Marianne S. Poruchynsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
SMAD4 expression in breast ductal carcinoma correlates with prognosis
Nannan Liu et al.
ONCOLOGY LETTERS (2015)
Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
Jessica J. Field et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states
T. Yoshida et al.
BRITISH JOURNAL OF CANCER (2014)
Differential Role of Snail1 and Snail2 Zinc Fingers in E-cadherin Repression and Epithelial to Mesenchymal Transition
Ana Villarejo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Role of Snail in EMT and Tumorigenesis
Yifan Wang et al.
CURRENT CANCER DRUG TARGETS (2013)
TGF-beta signaling and epithelial-mesenchymal transition in cancer progression
Yoko Katsuno et al.
CURRENT OPINION IN ONCOLOGY (2013)
Tubulin: an example of targeted chemotherapy
Jenny Seligmann et al.
FUTURE MEDICINAL CHEMISTRY (2013)
A Dynein Motor Attachment Complex Regulates TGF beta/Smad3 Signaling
Qunyan Jin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Androgen Receptor on the Move: Boarding the Microtubule Expressway to the Nucleus
Maria Thadani-Mulero et al.
CANCER RESEARCH (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
Panagiotis Papageorgis et al.
CANCER RESEARCH (2011)
Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
Medha S. Darshan et al.
CANCER RESEARCH (2011)
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Javier Cortes et al.
LANCET (2011)
OPINION Mitosis is not a key target of microtubule agents in patient tumors
Edina Komlodi-Pasztor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Activation of the Canonical Wnt/β-Catenin Pathway in ATF3-Induced Mammary Tumors
Leqin Yan et al.
PLOS ONE (2011)
The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer
Archana Dhasarathy et al.
PLOS ONE (2011)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Nucleocytoplasmic shuttling of Smad proteins
Caroline S. Hill
CELL RESEARCH (2009)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford et al.
CLINICAL CANCER RESEARCH (2009)
Kinesin-1 Regulates Microtubule Dynamics via a c-Jun N-terminal Kinase-dependent Mechanism
Vanessa Daire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Requirement of a Dynein Light Chain in TGFβ/Smad3 Signaling
Qunyan Jin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Differences in Paclitaxel and Docetaxel Interactions with Tubulin Detected by Mutagenesis of Yeast Tubulin
Robert D. Winefield et al.
CHEMMEDCHEM (2008)
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Transcription Factor NF-κB Is Transported to the Nucleus via Cytoplasmic Dynein/Dynactin Motor Complex in Hippocampal Neurons
Ilja Mikenberg et al.
PLOS ONE (2007)
Requirement for the dynein light chain km23-1 in a Smad2-dependent transforming growth factor-β signaling pathway
Qunyan Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer
E. A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-β Ligands
Julie Batut et al.
DEVELOPMENTAL CELL (2007)
Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-β-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses
L Levy et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer
K Yonemori et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines
SP Fink et al.
ONCOGENE (2003)
An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity
Z Xiao et al.
ONCOGENE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
